Nisa Investment Advisors
SLDB icon

Nisa Investment Advisors’s Solid Biosciences SLDB Stock Holding History

Nisa Investment Advisors’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.3K Hold
5,436
– – ﹤0.01% 1826
2026
Q1 		$39.1K Buy
5,436
+600
+12% +$3.85K ﹤0.01% 1773
2025
Q4 		$27.3K Sell
4,836
-55,700
-92% -$302K ﹤0.01% 1825
2025
Q3 		$374K Buy
60,536
+56,700
+1,478% +$332K ﹤0.01% 1098
2025
Q2 		$18.7K Sell
3,836
-1,610
-30% -$5.69K ﹤0.01% 1974
2025
Q1 		$20.1K Buy
5,446
+5,285
+3,283% +$22.6K ﹤0.01% 1875
2024
Q4 		$644 Buy
161
+107
+198% +$588 ﹤0.01% 2774
2024
Q3 		$376 Buy
+54
New +$438 ﹤0.01% 2769
2021
Q4 		– Sell
-453
Closed -$16K – 2312
2021
Q3 		$16K Hold
453
– – ﹤0.01% 2141
2021
Q2 		$25K Hold
453
– – ﹤0.01% 2094
2021
Q1 		$38K Sell
453
-100
-18% -$11.1K ﹤0.01% 2037
2020
Q4 		$63K Sell
553
-54
-9% -$3.42K ﹤0.01% 1922
2020
Q3 		$18K Hold
607
– – ﹤0.01% 2049
2020
Q2 		$27K Buy
607
+554
+1,045% +$23K ﹤0.01% 1714
2020
Q1 		$2K Hold
53
– – ﹤0.01% 2047
2019
Q4 		$4K Buy
+53
New +$5.85K ﹤0.01% 1950

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nisa Investment Advisors's SLDB Position: Q2 2026 in Review

Nisa Investment Advisors held its Solid Biosciences (SLDB) position steady in Q2 2026 at 5,436 shares worth $54.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1826.

Nisa Investment Advisors first reported a position in SLDB in Q4 2019 and has held it in 16 quarters since. The position peaked at $374K in Q3 2025. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Nisa Investment Advisors held 5,436 shares of Solid Biosciences worth $54.3K as of Q2 2026.
  • Nisa Investment Advisors left its Solid Biosciences share count unchanged in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1826 holding.
  • Nisa Investment Advisors first reported a position in Solid Biosciences in Q4 2019 and has held it in 16 quarters since.
  • Nisa Investment Advisors's Solid Biosciences position peaked at $374K in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.